Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AMRX

Amneal Pharmaceuticals Inc

Jun 09 • 04:00PM ET

14.69

+0.98 7.15 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Mid • NASD

Peers: TEVA VTRS BHC PRGO INDV ALKS LNTH KNSA HRMY OPK

| Held by: IJR VTI VB IWM VBR VXF XSMO SPSM IWO DFAS

Scroll to Statements

Index	RUT	P/E	39.38	EPS (ttm)	0.37	Insider Own	51.00%	Shs Outstand	319.00M	Perf Week	16.13%
Market Cap	4.69B	Forward P/E	12.92	EPS next Y	1.14	Insider Trans	-0.02%	Shs Float	156.32M	Perf Month	11.29%
Enterprise Value	7.27B	PEG	0.78	EPS next Q	0.23	Inst Own	47.40%	Short Float	4.82%	Perf Quarter	10.04%
Income	122.12M	P/S	1.54	EPS this Y	18.96%	Inst Trans	3.58%	Short Ratio	4.24	Perf Half Y	20.61%
Sales	3.05B	P/B	-	EPS next Y	15.14%	ROA	3.54%	Short Interest	7.53M	Perf YTD	16.59%
Book/sh	-0.14	P/C	23.22	EPS next 5Y	16.49%	ROE	-	52W High	15.42 -4.73%	Perf Year	93.04%
Cash/sh	0.63	P/FCF	22.83	EPS past 3/5Y	- -18.36%	ROIC	4.64%	52W Low	7.53 95.09%	Perf 3Y	502.05%
Dividend Est.	-	EV/EBITDA	11.17	Sales past 3/5Y	10.92% 8.66%	Gross Margin	38.66%	Volatility	3.95% 3.07%	Perf 5Y	149.83%
Dividend TTM	-	EV/Sales	2.39	EPS Y/Y TTM	1018.25%	Oper. Margin	14.58%	ATR (14)	0.45	Perf 10Y	-56.23%
Dividend Ex-Date	-	Quick Ratio	1.59	Sales Y/Y TTM	7.62%	Profit Margin	4.01%	RSI (14)	72.73	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	2.47	EPS Q/Q	403.46%	SMA20	14.88%	Beta	1.28	Target Price	17.20
Payout	0.00%	Debt/Eq	-	Sales Q/Q	3.90%	SMA50	14.42%	Rel Volume	1.35	Prev Close	13.71
Employees	8500	LT Debt/Eq	-	Earnings	Apr 22 BMO	SMA200	20.86%	Avg Volume	1.77M	Price	14.69
IPO	Dec 19, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	59.67% 0.40%	Trades		Volume	2,422,061	Change	7.15%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)